Armstrong, April W, Sang Hee Park, Viktor Chirikov, Pierre Nicolas, Wei-Jhih Wang, Matthew J Colombo, and Vardhaman Patel. 2022. “Optimizing the Treatment Sequence: The Cumulative Clinical Benefit of Treatment Initiation With Deucravacitinib Versus Apremilast over 52 Weeks in Patients With Moderate to Severe Plaque Psoriasis from the POETYK PSO-1 Trial”. SKIN The Journal of Cutaneous Medicine 6 (6):s62. https://doi.org/10.25251/skin.6.supp.62.